Dashboard
Manage Tickers

ELANElanco Animal Health Inc

NYSE elanco.com


$ 17.04 $ 0.28 (1.67 %)    

Thursday, 09-May-2024 12:14:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.60 $ 0.16 (0.04 %)
DIA $ 392.24 $ 2.13 (0.55 %)
SPY $ 518.90 $ 1.46 (0.28 %)
TLT $ 90.10 $ 0.06 (0.07 %)
GLD $ 215.77 $ 1.07 (0.5 %)
$ 16.89
$ 16.76
$ 17.03 x 500
$ 17.05 x 200
$ 16.58 - $ 17.04
$ 7.88 - $ 17.23
19,729,086
na
8.38B
$ 1.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 07-30-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
19 11-08-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 02-20-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-maintains-overweight-on-elanco-animal-health-raises-price-target-to-23
Barclays Maintains Overweight on Elanco An...
05/09/2024 15:07:23

Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from...

elanco-animal-healths-q1-earnings-show-improved-base-business-analyst-highlights-slightly-delayed-but-encouraging-pipeline
Elanco Animal Health's Q1 Earnings Show Im...
05/08/2024 18:28:59

Elanco Animal Health (NYSE: ELAN) reports Q1 results: adjusted EPS $0.34 (-26% Y/Y), sales $1.21B (-4% Y/Y). 2024 guidance: EPS...

why-upstart-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Upstart Shares Are Trading Lower By Ar...
05/08/2024 17:38:56

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 16:31:09

louisiana-pacific-posts-upbeat-results-joins-cricut-elanco-animal-american-public-education-and-other-big-stocks-moving-higher-on-wednesday
Louisiana-Pacific Posts Upbeat Results, Jo...
05/08/2024 15:11:22

elanco-animal-health-forecasts-2024-adjusted-ebitda-of-960m-1b-versus-prior-guidance-of-960m-101b
Elanco Animal Health Forecasts 2024 Adjust...
05/08/2024 10:35:31

elanco-animal-health-forecasts-2024-adjusted-eps-of-088-096-versus-prior-guidance-of-087-095-and-consensus-of-092
Elanco Animal Health Forecasts 2024 Adjust...
05/08/2024 10:34:15

elanco-animal-health-forecasts-2024-revenue-of-446b-4515b-versus-prior-guidance-of-445b-454b-and-consensus-of-449b
Elanco Animal Health Forecasts 2024 Revenu...
05/08/2024 10:32:45

elanco-animal-health-q1-2024-adj-eps-034-beats-026-estimate-sales-1205b-beat-1174b-estimate
Elanco Animal Health Q1 2024 Adj EPS $0.34...
05/08/2024 10:30:02

fda-approved-pradalex-pradofloxacin-injection-solution-for-certain-respiratory-diseases-in-cattle-and-swine-approves-new-antimicrobial-drug-for-cattle-and-swine-pradalex-is-sponsored-by-elanco-us
FDA Approved Pradalex (Pradofloxacin Injec...
04/09/2024 17:10:15

-Reuters

investor-activism-elanco-animal-health-settles-with-ancora-adds-new-board-members
Investor Activism: Elanco Animal Health Se...
04/01/2024 12:45:12

Elanco Animal Health settles with Ancora, expanding board to 14 members, including Ancora's nominees Craig Wallace and Kath...

elanco-animal-health-has-appointed-two-new-independent-directors-kathy-turner-and-craig-wallace-to-its-board-of-directors-effective-immediately-expanding-the-board-to-14-members
Elanco Animal Health Has Appointed Two New...
04/01/2024 10:37:25

bloomberg-reported-late-sunday-activist-investor-ancora-secures-two-elanco-board-seats
Bloomberg Reported Late Sunday: Activist I...
04/01/2024 08:43:06

https://www.bloomberg.com/news/articles/2024-04-01/activist-ancora-is-said-to-win-two-board-seats-at-elanco

piper-sandler-reiterates-neutral-on-elanco-animal-health-raises-price-target-to-18
Piper Sandler Reiterates Neutral on Elanco...
03/12/2024 14:08:27

Piper Sandler analyst David Westenberg reiterates Elanco Animal Health (NYSE:ELAN) with a Neutral and raises the price targe...

goldman-sachs-maintains-sell-on-elanco-animal-health-raises-price-target-to-14
Goldman Sachs Maintains Sell on Elanco Ani...
02/27/2024 16:17:14

Goldman Sachs analyst Nathan Rich maintains Elanco Animal Health (NYSE:ELAN) with a Sell and raises the price target from $1...

morgan-stanley-maintains-overweight-on-elanco-animal-health-raises-price-target-to-17
Morgan Stanley Maintains Overweight on Ela...
02/27/2024 15:56:22

Morgan Stanley analyst Erin Wright maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target ...

breaking-down-elanco-animal-health-6-analysts-share-their-views
Breaking Down Elanco Animal Health: 6 Anal...
02/27/2024 15:00:59

barclays-maintains-overweight-on-elanco-animal-health-raises-price-target-to-19
Barclays Maintains Overweight on Elanco An...
02/27/2024 14:35:57

Barclays analyst Balaji Prasad maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and raises the price target from...

this-pet-health-company-sees-growing-demand-for-farm-animal-products-cost-savings-from-restructuring
This Pet Health Company Sees Growing Deman...
02/26/2024 15:54:23

Elanco Animal Health reports Q4 2023 revenue of $1.035 billion, exceeding consensus. Explore insights into pet and farm animal ...

elanco-animal-health-shares-are-trading-higher-after-the-company-reported-mixed-q4-earnings-and-issued-2024-guidance
Elanco Animal Health shares are trading hi...
02/26/2024 11:45:14

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION